| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences, Inc. (NERV) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. NERV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.25M | $13.48M | - | |
| Pres | 1.50M | $8.98M | - | |
| CFO | 500.0K | $3.00M | - | |
| Dir | 364.5K | $2.18M | - | |
| Dir | 50.0K | $299.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2018 | Luthringer Remy | CEO | Sale+OE | 2,604 | $7.46 | $19,425.84 | -7.4% | |
| Dec 17, 2018 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 2,728 | $7.46 | $20,350.88 | -11.9% | |
| Dec 12, 2018 | Russell Richard E. | President | Sell | 3,117 | $7.96 | $24,811.32 | -7.8% | |
| Dec 11, 2018 | Doyle William F53 | Director | Buy | 6,000 | $7.97 | $47,800.00 | +19.2% | |
| Nov 20, 2018 | Doyle William F53 | Director | Buy | 2,000 | $8.20 | $16,400.00 | +15.9% | |
| Oct 11, 2018 | Doyle William F53 | Director | Buy | 600 | $10.00 | $6,000.00 | +5.0% | |
| Oct 1, 2018 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 25,000 | $12.06 | $301,520.00 | -45.4% | |
| Oct 1, 2018 | Index Venture Associates III Ltd | 10% Owner | Sell | 15,444 | $12.35 | $190,747.30 | -0.3% | |
| Sep 28, 2018 | Index Venture Associates III Ltd | 10% Owner | Sell | 66,273 | $12.59 | $834,617.91 | -0.7% | |
| Sep 17, 2018 | Doyle William F53 | Director | Buy | 1,800 | $10.50 | $18,900.00 | +17.6% |